Compounded GLP-1 Therapy for Individualized Patient Care

Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Compounded GLP-1 medications are prescribed only when a licensed healthcare provider determines, based on an individual patient’s medical needs, that an FDA-approved drug is not appropriate or that a clinically significant difference exists, such as dosage form, strength, or excipient composition.

SmartPharmaRx includes Niacinamide (B3) and Dexpanthenol (B5) in our GLP-1 formulations for specific clinical reasons — each additive is chosen to address known physiological side effects of GLP-1 therapy, not as a filler.

B3 (Niacinamide) supports energy metabolism and cellular repair via NAD+ production — particularly useful during caloric restriction. It also helps protect and repair the gut lining, which is directly relevant given that GLP-1 medications slow gastric emptying and increase GI stress. Additionally, it provides anti-inflammatory support for the metabolic conditions many of these patients already have.

B5 (Dexpanthenol) is the injectable form of Pantothenic Acid, which the body uses to produce Coenzyme A — a key player in fat and carbohydrate metabolism. Its standout role in this formulation is gut motility support. Dexpanthenol is clinically recognized for helping counter intestinal slowdown, which directly addresses the constipation, bloating, and nausea commonly reported by patients on GLP-1 therapy.

Both are water-soluble B vitamins with established safety profiles in injectable use — no accumulation risk, and well-tolerated across patient populations.